MedTrace Logo

Geriatric-CO-mAnagement for Cardiology Patients in the Hospital

NCT02890927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 454

Last updated 2020-02-13

No results posted yet for this study

Summary

The primary objective of the evaluation study is to determine if geriatric co-management is superior to standard of care in preventing functional decline in older patients admitted for acute heart disease or Transcatheter Aortic Valve Implementation (TAVI) to the cardiology units of the University Hospitals Leuven.

Conditions

  • Geriatric Assessment
  • Health Services for the Aged
  • Cardiovascular Diseases
  • Activities of Daily Living
  • Delirium
  • Frail Elderly
  • Length of Stay

Interventions

OTHER

Cardio-geriatric co-management

A comprehensive geriatric assessment on admission will stratify patients in groups: 1. Low risk patients are expected to do well and will not receive co-management. 2. Medium risk patients are expected to develop complications. A geriatric nurse will visit the cardiology wards daily to co-manage these patients aiming to prevent complications by coordinating interdisciplinary care, implementing protocols, perform assessments and bedside education. The geriatric nurse will work collaboratively with the cardiology ward staff based on a shared decision making. Patients will receive early rehabilitation and discharge planning. 3. High risk patients have an acute geriatric syndrome. The geriatric nurse will visit the cardiology wards (see above), and a geriatrician will co-manage the acute geriatric syndrome(s). The geriatrician will work collaboratively with the cardiology ward staff based on a shared decision making. Patients will receive early rehabilitation and discharge planning.

Sponsors & Collaborators

  • KU Leuven

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Johan Flamaing, PhD, MD · Universitaire Ziekenhuizen KU Leuven

  • Koen Milisen, PhD, MSN · University of Leuven

  • Mieke Deschodt, PhD, MSN · University of Leuven

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-12-31
Completion
2019-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02890927 on ClinicalTrials.gov